Overcoming methodical limits of standard <i>RHD</i> genotyping by next‐generation sequencing

Abstract

Our data suggest that next-generation sequencing offers a new development for high-throughput and clonal sequencing for molecular RHD genotyping. However, further attempts in the methodical set-up have to be undertaken prior to validation and introduction as a routine service.